Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) said it plans to acquire 50.26% stake in Pharma firm for CNY 499.6 million ($68.41 million). The company said it will own 75.9% stake in the Pharma firm after the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.3 CNY | +2.97% | +2.19% | -13.67% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.67% | 92Cr | |
+29.98% | 68TCr | |
+31.77% | 59TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.51% | 24TCr | |
+9.40% | 21TCr | |
-8.79% | 20TCr | |
+7.09% | 17TCr |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Guizhou Sanli Pharma Plans Acquisition for CNY 499.6 Million